Genetic Signatures Limited (GSS:ASX) Investor Relations Material

Overview

Genetic Signatures Limited is a molecular diagnostic company that offers real-time polymerase chain reaction-based products to detect infectious diseases under the brand EasyScreen. The Australian company also develops the MDx 3Base platform technology, which allows hospital and pathology laboratories to screen for various infectious pathogens. Since its establishment in 2001, Genetic Signatures Limited has expanded its operations to North America, Europe, the Middle East, and Africa.

Annual Reports

Frequently Asked Questions

What is Genetic Signatures Limited's ticker?

Genetic Signatures Limited's ticker is GSS

What exchange is Genetic Signatures Limited traded on?

The company's shares trade on the ASX stock exchange

Where are Genetic Signatures Limited's headquarters?

They are based in Newtown, Australia

How many employees does Genetic Signatures Limited have?

There are 51-200 employees working at Genetic Signatures Limited

What is Genetic Signatures Limited's website?

It is https://geneticsignatures.com/us/

What type of sector is Genetic Signatures Limited?

Genetic Signatures Limited is in the Healthcare sector

What type of industry is Genetic Signatures Limited?

Genetic Signatures Limited is in the Biotechnology industry

Who are Genetic Signatures Limited's peers and competitors?

The following five companies are Genetic Signatures Limited's industry peers:

- Proteomics International

- Fate Therapeutics

- Idera Pharmaceuticals, Inc.

- Alder Biopharmaceuticals Inc

- Insys Therapeutics Inc